Allysia Finley slams FDA bureaucracy for delaying life-saving cancer drug

Name: Allysia Finley slams FDA bureaucracy for delaying life-saving cancer drug
Uploaded: 2026-08-01T19:45:41Z
Duration: 32 s
Description: Allysia Finley hits back at the FDA bureaucracy for delaying approval of a promising melanoma immunotherapy drug, urging agency leaders to prioritize patients over administrative control.

The Journal Editorial Report · FNC · Aired Sat, Aug 1 · 32s

Watch Now

Already a subscriber?

Allysia Finley hits back at the FDA bureaucracy for delaying approval of a promising melanoma immunotherapy drug, urging agency leaders to prioritize patients over administrative control.